Abstract |
A range of substituted N-alkylisatins were synthesized and their cytotoxicity evaluated against several cancer cell lines in vitro. SAR studies indicated that the introduction of an aromatic ring with a one or three carbon atom linker at N1 enhanced the activity from that of the allyl, 2'-methoxyethyl, and 3'-methylbutyl N-substituted isatins. Furthermore, electron-withdrawing groups substituted at the meta or para position of the ring were favored over the ortho orientation. Of the 24 compounds screened, nine displayed sub-micromolar IC50 values and in general demonstrated greater selectivity toward leukemia and lymphoma cell lines over any of the carcinoma cell lines tested. 5,7-Dibromo-N-(p-methylbenzyl)isatin (6) was the most active compound, inhibiting the metabolic activity of both U937 and Jurkat cancer cell lines at 0.49 muM. Various N-alkylisatins were also found to dramatically alter lymphocyte morphology, destabilize microtubules, inhibit tubulin polymerization, induce G2/M cell cycle arrest, and activate the effector caspase-3 and -7.
|
Authors | Kara L Vine, Julie M Locke, Marie Ranson, Stephen G Pyne, John B Bremner |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 50
Issue 21
Pg. 5109-17
(Oct 18 2007)
ISSN: 0022-2623 [Print] United States |
PMID | 17887662
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 5,7-dibromo-N-(4-methylbenzyl)isatin
- Antineoplastic Agents
- Biopolymers
- Tubulin
- Isatin
- Caspase 3
- Caspase 7
|
Topics |
- Antineoplastic Agents
(chemical synthesis, pharmacology)
- Apoptosis
- Biopolymers
- Caspase 3
(metabolism)
- Caspase 7
(metabolism)
- Cell Cycle
(drug effects)
- Cell Line, Tumor
- Drug Screening Assays, Antitumor
- Enzyme Activation
- Humans
- Isatin
(analogs & derivatives, chemical synthesis, pharmacology)
- Lymphocytes
(drug effects, pathology)
- Microtubules
(drug effects, ultrastructure)
- Stereoisomerism
- Structure-Activity Relationship
- Tubulin
(chemistry)
|